Delivery formulations

64 Results

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Transforming Clinical Development

Transforming Clinical Development

Content provided by PerkinElmer | 01-May-2021 | White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Flow Cytometry Services

Flow Cytometry Services

Content provided by Q² Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Controlled Nucleation: more than just a homogenization tool

Controlled Nucleation: more than just a homogenization tool

Content provided by Telstar Life Science Solutions | 30-Sep-2019 | Case Study

A new vacuum induced nucleation method in the freeze-drying process, Telstar Lyonuc, reduces the duration of the primary drying cycle and ensures the homogenization...

From Candidate to Clinic- European Capabilities

From Candidate to Clinic- European Capabilities

Content provided by Catalent | 22-Oct-2018 | White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Customized Fill Release in Gelatine Soft Capsules

Customized Fill Release in Gelatine Soft Capsules

Content provided by Gelita AG | 07-May-2018 | Application Note

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Content provided by Catalent | 05-Mar-2018 | White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Steridose

Optimizing vessel geometry for mag drive agitators

Content provided by Steridose, Inc | 14-Sep-2017 | White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

First-in-Human Development Strategies

First-in-Human Development Strategies

Content provided by Catalent | 01-May-2017 | Insight Guide

Crucial and cost-effective factors to consider when transforming a pre-clinical development compound into a first-in-human, early-phase drug candidate....

Producing the perfect soft gel

Producing the perfect soft gel

Content provided by Leading manufacturer of gelatine and collagen peptides | 17-Jan-2017 | White Paper

This white paper outlines the key considerations to ensure gelatin is enhanced for soft gel formulation, efficient gel production and optimal API delivery...

Patient-Centric Drug-Development Process

Patient-Centric Drug-Development Process

Content provided by Catalent | 28-Nov-2016 | Insight Guide

For large and small pharmaceutical companies alike; developing a new drug is fraught with risk. Patient-centric drug development and optimization is both...

Choosing the Right Size Sphere

Choosing the Right Size Sphere

Content provided by Colorcon Inc. | 21-Nov-2016 | White Paper

Choosing the right size sugar sphere, for a multiparticulate dosage form is imperative.  Size matters; not only to achieve a robust formulation and efficient...

Experience foam for topical drug delivery

Experience foam for topical drug delivery

Content provided by Gattefossé | 14-Nov-2016 | White Paper

Pharmaceutical foams are becoming more popular probably due to more topical medicines being switched to OTC and the need to innovate and differentiate...

FDA Focus̶ Product Design and Post Approval Changes

FDA Focus̶ Product Design and Post Approval Changes

Content provided by Colorcon Inc. | 19-Sep-2016 | White Paper

Review a new Colorcon Technical Paper offering a summary of key points presented in the recent US Center for Drug Evaluation and Research (CDER) Guidance...

New Organic Coating System to Modulate Drug Release

New Organic Coating System to Modulate Drug Release

Content provided by Colorcon Inc. | 09-May-2016 | White Paper

A Colorcon Study, Effect of Coating Weight Gain and Pore-Former Level on Drug Release with a Fully Formulated Ethylcellulose Barrier Membrane Coating System,...

Abbott_Whitepaper-Considerations-in-purchasing-a-LIMS_Web

Considerations in Purchasing a LIMS

Content provided by Abbott Informatics | 27-Apr-2016 | White Paper

Many scientific enterprises find themselves in need of a Laboratory Information Management System (LIMS) to replace an incumbent system, whether an existing...

Single-Pass TFF and the New Era of Bioprocessing

Single-Pass TFF and the New Era of Bioprocessing

Content provided by Pall Biotech | 11-Apr-2016 | White Paper

Learn how single-pass tangential flow filtration (SPTFF) technology is revolutionizing current and future bioprocessing platforms with its implementations...

White paper: ensure quality in novel dosage forms

White paper: ensure quality in novel dosage forms

Content provided by Stable Micro Systems | 14-Mar-2016 | White Paper

From oral sprays to pastilles and capsules, pharmaceutical products must increasingly cater for a wider range of preferences. Download this free white...

Leveraging ADVASEPT® Technology

Leveraging ADVASEPT® Technology

Content provided by Catalent | 14-Dec-2015 | Case Study

Catalent’s ADVASEPT® Technology is an advanced aseptic manufacturing process that leverages blow-fill-seal (BFS) technology to create a glass free container...

Article on Viral Clearance for Biopharmaceuticals

Article on Viral Clearance for Biopharmaceuticals

Content provided by Catalent | 24-Aug-2015 | White Paper

Viral clearance studies are mandated prior to entering clinical trials and for commercial launch of biopharmaceuticals.  These studies are a key component...

Evonik Solutions for Alcohol Induced Dose Dumping

Evonik Solutions for Alcohol Induced Dose Dumping

Evonik Health Care | Recorded the 10-Sep-2015 | Webinar

Details the physiology related to alcohol consumption and its subsequent impact on drug release. Effective formulation strategies for meeting the physiological...

Glass to plastic: a gas barrier PFS for biologics

Glass to plastic: a gas barrier PFS for biologics

Content provided by Nemera | 13-Jul-2015 | Research Study

Gas permeability remains a main challenge of plastic prefilled syringes, preventing an increased uptake in some applications. Nemera has developed an innovative...

GELITA® RXL technology prevents cross-linking

GELITA® RXL technology prevents cross-linking

Content provided by Gelita AG | 06-Apr-2015 | Data Sheet

The GELITA Pharmaceutical Competence Team has developed a new technology: GELITA® RXL (Reduced Cross-Linking gelatine) that adds extra value to gelatine...

Meaningful Metrics – A CMO Perspective

Meaningful Metrics – A CMO Perspective

Content provided by Patheon Inc | 19-Jan-2015 | White Paper

Learn about the roles of sponsors and their contract manufacturing organization (CMO) partners regarding metrics, what metrics to measure, how to manage...

Solid Lipid Excipients: Born to be Extruded !

Solid Lipid Excipients: Born to be Extruded !

Content provided by Gattefossé | 17-Nov-2014 | White Paper

Functional excipients are critical to the successful application of HME to resolve formulation challenges. Whilst polymers show potential in both controlled...

Croda

Maximize Excipient Purity to Optimize Efficacy

Content provided by Croda Inc | 29-Sep-2014 | Information Request

The purity of your excipient can have a profound impact on your formulation’s performance, affecting both the stability of the drug and the final formulation....

12 Weeks to Phase I Clinical Trial Materials

12 Weeks to Phase I Clinical Trial Materials

Content provided by Patheon Inc | 01-Sep-2014 | Clinical Study

Learn how in twelve weeks from receiving your API, you can have bulk clinical trial materials for First in Man trials. The Quick to Clinic™ program includes...

Method Development and Validation for Nutraceuticals

Method Development and Validation for Nutraceuticals

Content provided by RSSL | 12-Dec-2013 | White Paper

Nutraceutical is a term formed from the amalgamation of the words “pharmaceutical” and “nutrition” by Dr Stephen Felice in 1989. Others have since tried...

Mitigating Medication Errors with Tablet Design

Mitigating Medication Errors with Tablet Design

Content provided by Colorcon Inc. | 09-Dec-2013 | White Paper

Medical prescription drug errors by doctors, pharmacists and patients account for 1.5 million incidences of sickness, injuries or deaths in the U.S. each...

NEOBEE® MCTs Enhance Pharmaceutical Bioavailability

NEOBEE® MCTs Enhance Pharmaceutical Bioavailability

Content provided by Stepan Lipid Nutrition | 04-Nov-2013 | White Paper

An efficient solvent for many lipophylic drugs and vitamins, NEOBEE® MCTs emulsify in aqueous environments and help uptake in intestinal cells. They are...

Follow us

Product Innovations